ASX-100 / Asalyxa Bio - LARVOL DELTA

Why Is the Australian Health Sector So Far behind in Practising Climate-Related Disclosures? (PubMed, Int J Environ Res Public Health) - "The health sector in Australia and the ASX100 is lagging far behind in the implementation of carbon management and climate risk analysis...The reasons for this inaction represent a knowledge gap in the literature, but several hypotheses are formulated, such as the lack of pressure from public authorities. At the level of the ten largest healthcare companies in the world, this failure to act is not systemic, so the scope of analysis must be broadened to see a pattern emerging."

Journal

Potential protective effect of astaxanthin on ovary ischemia-reperfusion injury. (PubMed, Iran J Basic Med Sci) - "In addition, inflammatory cells and necrotic cells in the I/R group were not observed in I/R+ASX50 and I/R+ASX100 groups. As a result, it was determined that ASX has a strong protective role against oxidative damage in the treatment of ovarian ischemia-reperfusion injury."

Journal • Cardiovascular • Hematological Disorders • Reperfusion Injury • CASP3 • IL6